Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Inflammatory Bowel Diseases

  Free Subscription


1 Aliment Pharmacol Ther
2 BMC Gastroenterol
1 Br J Surg
6 Clin Gastroenterol Hepatol
1 Dig Dis Sci
1 Dis Colon Rectum
2 Gastroenterology
1 Gut
3 Inflamm Bowel Dis
4 J Crohns Colitis
1 J Gastroenterol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. FEAGAN BG, Khanna R, Sandborn WJ, Vermeire S, et al
    Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
    Aliment Pharmacol Ther. 2021 Oct 6. doi: 10.1111/apt.16626.
    PubMed         Abstract available

    BMC Gastroenterol

  2. SULKANEN E, Repo M, Huhtala H, Hiltunen P, et al
    Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study.
    BMC Gastroenterol. 2021;21:364.
    PubMed         Abstract available

  3. MU X, Fardy J, Reid S, Trahey J, et al
    Severe drug-associated colitis with Crohn's features in setting of ixekizumab therapy for chronic plaque psoriasis.
    BMC Gastroenterol. 2021;21:361.
    PubMed         Abstract available

    Br J Surg

  4. What has caused the stricture in the small bowel and what has developed as a result?
    Br J Surg. 2021;108:744.

    Clin Gastroenterol Hepatol

  5. KUMAR R, Zaghiyan K, Ha C
    Lower Surgical Risks in "Contemporary" IBD Cohorts: A Reflection of Better Quality of Care or Statistics?
    Clin Gastroenterol Hepatol. 2021;19:2029-2030.

  6. DEBNATH P, Rathi P
    Outcomes Related to Mucosal Healing in Patients With Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:2214.

  7. FENSTER M, Alayo QA, Khatiwada A, Wang W, et al
    Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
    Clin Gastroenterol Hepatol. 2021;19:2207-2209.
    PubMed         Abstract available

  8. QIAN AS, Nguyen NH, Elia J, Ohno-Machado L, et al
    Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2021;19:2054-2063.
    PubMed         Abstract available

  9. SCOTT FI, Hans AK, Gerich ME, Fennimore B, et al
    Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's Disease.
    Clin Gastroenterol Hepatol. 2021;19:2082-2092.
    PubMed         Abstract available

  10. SOH H, Lee HJ, Han K, Park S, et al
    Atopic Diseases Are Associated With Development of Inflammatory Bowel Diseases in Korea: A Nationwide Population-based Study.
    Clin Gastroenterol Hepatol. 2021;19:2072-2081.
    PubMed         Abstract available

    Dig Dis Sci

  11. RABINOWITZ LG, Zylberberg HM, Yang J, Gold SL, et al
    De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Oct 6. pii: 10.1007/s10620-021-07257.
    PubMed         Abstract available

    Dis Colon Rectum

  12. YAO J, Jiang Y, Ke J, Lu Y, et al
    A Validated Prognostic Model and Nomogram to Predict Early-Onset Complications Leading to Surgery in Patients With Crohn's Disease.
    Dis Colon Rectum. 2021;64:697-705.
    PubMed         Abstract available


  13. LIMA S, Gogokhia L, Viladomiu M, Chou L, et al
    Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Gastroenterology. 2021 Oct 1. pii: S0016-5085(21)03610.
    PubMed         Abstract available

  14. KHANNA R, Wilson AS, Gregor JC, Prowse KL, et al
    Clinical Guidelines for the Management of Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03521.


  15. JUZNIC L, Peuker K, Strigli A, Brosch M, et al
    SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation.
    Gut. 2021;70:485-498.
    PubMed         Abstract available

    Inflamm Bowel Dis

  16. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 Oct 6. pii: 6382159. doi: 10.1093.

  17. RAMAN M, Rajagopalan V, Kaur S, Reimer RA, et al
    Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Oct 4. pii: 6380888. doi: 10.1093.
    PubMed         Abstract available

  18. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed         Abstract available

    J Crohns Colitis

  19. AARDOOM MA, Klomberg RCW, Kemos P, Ruemmele FM, et al
    The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry.
    J Crohns Colitis. 2021 Oct 2. pii: 6380289. doi: 10.1093.
    PubMed         Abstract available

  20. ILVEMARK JFKF, Hansen T, Goodsall TM, Seidelin JB, et al
    Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement.
    J Crohns Colitis. 2021 Oct 6. pii: 6382324. doi: 10.1093.
    PubMed         Abstract available

  21. JOJART B, Molnar T, Szabo V, Varga A, et al
    Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 7. pii: 6383122. doi: 10.1093.

  22. WALENTYNOWICZ M, van de Pavert I, Fierens L, Coenen S, et al
    Inflammatory Bowel Disease-related Behaviours [IBD-Bx] questionnaire: Development, validation, and prospective associations with fatigue.
    J Crohns Colitis. 2021 Oct 8. pii: 6383644. doi: 10.1093.
    PubMed         Abstract available

    J Gastroenterol

  23. ANDO K, Fujiya M, Watanabe K, Hiraoka S, et al
    A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
    J Gastroenterol. 2021 Oct 5. pii: 10.1007/s00535-021-01829.
    PubMed         Abstract available

    PLoS One

  24. CREEMERS RH, Rezazadeh Ardabili A, Jonkers DM, Leers MPG, et al
    Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    PLoS One. 2021;16:e0258271.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.